10 Aug 2026
Design and optimization of nafimidone-inspired hybrid scaffolds targeting NaV1.2 for antiepileptic therapy with reduced cardiac liabilityPublisher siteBioorganic Chemistry, Pharmacological Receptor Mechanisms and Effects
Active, last published 2026
In computational drug discovery methods
Peter A.
Sidhom
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
Tanta University
Egypt
Claim Your ProfileEgypt18
H-index
762
Citations
Peter has not officially claimed their profile. If you are Peter, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
eter A. Sidhom is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Peter's work has been cited 762 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×17Synthesis and biological activity×16Drug Transport and Resistance Mechanisms×7Boron and Carbon Nanomaterials Research×7Crystallization and Solubility Studies×7
04 · Where I am
Affiliations
Affiliation on published researchTanta University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
16 works24 Apr 2026Open access
Paeoniflorin Ameliorates Cecal Ligation and Puncture-Induced Acute Lung Injury in Mice by Modulating Oxidative Stress, Apoptosis, and Inflammation: Shedding Light on the Role of the JAK2/STAT3 PathwayPublisher sitePharmaceuticals, Cytokine Signaling Pathways and Interactions
20 Apr 2026Open access
Effect of HIV-1 subtype-specific Tat protein polymorphisms on Tat-TAR interactionPublisher sitePLoS ONE, HIV Research and Treatment
6 Mar 2026
InhibitWin duo: Rational design and structural insights into dual PARP/HDAC inhibitors for synergistic DNA repair disruption and epigenetic modulationPublisher siteEuropean Journal of Medicinal Chemistry, PARP inhibition in cancer therapy
25 Nov 2024Open access6cites
Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulationsPublisher sitePLoS ONE, Cancer therapeutics and mechanisms
22 Nov 2024Open access3cites
A DFT investigation on the potential of beryllium oxide (Be12O12) as a nanocarrier for nucleobasesPublisher sitePLoS ONE, Muon and positron interactions and applications
15 Nov 2024Open access5cites
Repurposing of drug candidates against Epstein–Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical studyPublisher sitePLoS ONE, Viral-associated cancers and disorders
15 Nov 20242cites
Planar π‒π stacking interactions stabilized 3D structure of a dimeric Zn(II) complex: Crystal structure, DFT calculations, and anti-Alzheimer and anti-Parkinson potentialsPublisher siteJournal of Molecular Structure, Crystallography and molecular interactions
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Peter?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you